As a leader in microbial biotechnology, and leveraging on its exclusive human microbiota big data among Asians, the research team pioneered the use of microbiome with evidence-based science for over a decade to tackle a myriad of diseases including COVID-19, colorectal cancer, obesity, eczema, and autism.
The gut microbiota interact with our human cells to regulate many physiological processes, such as metabolism and immune response, dysbiosis may lead to Weakened Immunity . By G-NiiB testing and technologies, we aim at modulating human gut microbiome to boost our Immunity.
誰主命運.jpg)
如何改善你的免疫力.jpg)
